kynurenine has been researched along with Hypotension in 4 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Kynurenine is a potential contributor to hypotension in animal and human sepsis." | 7.81 | Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels. ( Akahori, T; Feng, GG; Fujiwara, Y; Hatakeyama, N; Kinoshita, H; Li, J; Nakamura, E; Sakakibara, K; Yasuda, Y, 2015) |
| "Patients (n = 16) with septic shock had indoleamine 2,3-dioxygenase activity assessed as the kynurenine-to-tryptophan ratio, and the severity of hypotension was determined by their inotrope requirements." | 7.77 | Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. ( Celermajer, DS; Changsirivathanathamrong, D; dos Remedios, CG; Duflou, J; Gebski, V; Maghzal, GJ; Mak, WM; Rajbhandari, D; Stocker, R; Wang, Y; Woolfe, C, 2011) |
| "Kynurenine is a potential contributor to hypotension in animal and human sepsis." | 3.81 | Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels. ( Akahori, T; Feng, GG; Fujiwara, Y; Hatakeyama, N; Kinoshita, H; Li, J; Nakamura, E; Sakakibara, K; Yasuda, Y, 2015) |
| "Patients (n = 16) with septic shock had indoleamine 2,3-dioxygenase activity assessed as the kynurenine-to-tryptophan ratio, and the severity of hypotension was determined by their inotrope requirements." | 3.77 | Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. ( Celermajer, DS; Changsirivathanathamrong, D; dos Remedios, CG; Duflou, J; Gebski, V; Maghzal, GJ; Mak, WM; Rajbhandari, D; Stocker, R; Wang, Y; Woolfe, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakakibara, K | 1 |
| Feng, GG | 1 |
| Li, J | 1 |
| Akahori, T | 1 |
| Yasuda, Y | 1 |
| Nakamura, E | 1 |
| Hatakeyama, N | 1 |
| Fujiwara, Y | 1 |
| Kinoshita, H | 1 |
| Changsirivathanathamrong, D | 1 |
| Wang, Y | 1 |
| Rajbhandari, D | 1 |
| Maghzal, GJ | 1 |
| Mak, WM | 1 |
| Woolfe, C | 1 |
| Duflou, J | 1 |
| Gebski, V | 1 |
| dos Remedios, CG | 1 |
| Celermajer, DS | 1 |
| Stocker, R | 1 |
| Eiserich, JP | 1 |
| Hayakawa, KA | 1 |
| Cross, CE | 1 |
| Oxenkrug, GF | 1 |
4 other studies available for kynurenine and Hypotension
| Article | Year |
|---|---|
Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Humans; Hypotension; In Vitro Techniques; Indol | 2015 |
Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hypotension; Indoleamine-Pyrrole 2,3,-Dioxygenase; I | 2011 |
Sepsis and hypotension: enter kynurenine, move over nitric oxide.
Topics: Female; Humans; Hypotension; Kynurenine; Male; Shock, Septic; Tryptophan | 2011 |
Kynurenine and hypotension: historic perspectives.
Topics: Female; Humans; Hypotension; Kynurenine; Male; Shock, Septic; Tryptophan | 2012 |